Venrock Healthcare Capital Par's Net Worth

Venrock Healthcare Capital Par's net worth is estimated to be at least $63,599,975.91 as of 12/23/2024. CoreStreet's estimation of Venrock Healthcare Capital Par's net worth is based on their sale of stock and current holding of stock.

Venrock Healthcare Capital Par is Major Shareholder at Kalvista Pharmaceuticals Inc. They have executed at least 41 trades of stock as per SEC Form 4 filings. Their most recent trade was for 29,747 units of KALV stock on 02/08/2024. Their biggest sale was on 03/18/2019 when they sold 500,000 units of Kalvista Pharmaceuticals Inc stock for $14,375,000.00. They typically trade 8 times per year.

Total value of insider buys:
  • $46,846,567.59
Total value of insider sells:
  • $16,753,408.32
Most recent insider trade:
  • Feb. 8, 2024

Venrock Healthcare Capital Par's Insider Trading History

Kalvista Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Feb. 8, 2024
Major Shareholder29,747$14.70Buy$437,280.90
Feb. 6, 2024
Major Shareholder4,474$14.74Buy$65,946.76
Jan. 29, 2024
Major Shareholder80,600$14.22Buy$1,146,132.00
Jan. 26, 2024
Major Shareholder4,174$12.98Buy$54,178.52
Jan. 24, 2024
Major Shareholder20,686$12.44Buy$257,333.84
Jan. 22, 2024
Major Shareholder67,546$12.55Buy$847,702.30
Jan. 18, 2024
Major Shareholder39,680$12.51Buy$496,396.80
Jan. 16, 2024
Major Shareholder19,599$12.73Buy$249,495.27
Jan. 10, 2024
Major Shareholder47,700$12.67Buy$604,359.00
Jan. 8, 2024
Major Shareholder69,184$12.44Buy$860,648.96
Jan. 3, 2024
Major Shareholder17,605$12.20Buy$214,781.00
Dec. 29, 2023
Major Shareholder6,013$12.49Buy$75,102.37
Dec. 27, 2023
Major Shareholder41,514$11.97Buy$496,922.58
March 18, 2019
Major Shareholder500,000$28.75Sell$14,375,000.00
Tricida IncTitleAmountPriceTypeTotal Value
Oct. 26, 2022
Major Shareholder2,367,174$0.46Sell$1,088,900.04
Oct. 24, 2022
Major Shareholder2,113,948$0.61Sell$1,289,508.28
Oct. 19, 2022
Major Shareholder311,466$10.51Buy$3,273,507.66
Oct. 17, 2022
Major Shareholder170,292$11.67Buy$1,987,307.64
Oct. 10, 2022
Major Shareholder80,314$11.89Buy$954,933.46
Oct. 7, 2022
Major Shareholder28,900$12.00Buy$346,800.00
Oct. 3, 2022
Major Shareholder268,736$11.27Buy$3,028,654.72
Sept. 28, 2022
Major Shareholder76,600$9.92Buy$759,872.00
Sept. 26, 2022
Major Shareholder395,614$8.56Buy$3,386,455.84
July 29, 2022
Major Shareholder18,900$9.21Buy$174,069.00
July 25, 2022
Major Shareholder29,199$8.95Buy$261,331.05
July 22, 2022
Major Shareholder15,000$9.21Buy$138,150.00
July 20, 2022
Major Shareholder25,000$9.54Buy$238,500.00
July 18, 2022
Major Shareholder100,000$9.02Buy$902,000.00
July 14, 2022
Major Shareholder36,717$9.85Buy$361,662.45
July 5, 2022
Major Shareholder32,500$9.53Buy$309,725.00
June 30, 2022
Major Shareholder11,958$9.66Buy$115,514.28
June 28, 2022
Major Shareholder34,366$9.71Buy$333,693.86
June 24, 2022
Major Shareholder149,120$9.68Buy$1,443,481.60
June 22, 2022
Major Shareholder142,900$10.90Buy$1,557,610.00
June 16, 2022
Major Shareholder5,951$9.69Buy$57,665.19
June 13, 2022
Major Shareholder50,000$8.14Buy$407,000.00
June 6, 2022
Major Shareholder91,506$9.35Buy$855,581.10
June 2, 2022
Major Shareholder61,722$8.78Buy$541,919.16
Altimmune IncTitleAmountPriceTypeTotal Value
June 15, 2020
Major Shareholder1,500,000$7.54Buy$11,310,000.00
May 28, 2020
Major Shareholder201,474$8.72Buy$1,756,853.28
May 26, 2020
Major Shareholder700,000$9.34Buy$6,538,000.00